Compugen Ltd. (CGEN) Income Statement
CGEN 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsCGEN revenue and net income
Where CGEN's revenue goes
2025Each bar shows an amount and its share of revenue. CGEN kept 48.6% of revenue as net income.
CGEN profit margins
CGEN growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +161.1% | +113.3% | +105.2% | +22.9% |
| Gross profit | +218.6% | +113.5% | +100.9% | +23.6% |
| Operating income | — | — | — | — |
| Net income | — | — | — | — |
| EPS (diluted) | — | — | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
CGEN quarterly EPS vs estimates
Compugen beat the analyst EPS estimate in 6 of the last 8 quarters. Next report: November 9, 2026 (estimate $-0.08).
CGEN income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $72.8M | $27.9M | $33.5M | $7.5M | $6.0M | $2.0M | $0 | $17.8M | $0 | $712,000 |
| Cost of revenue | $9.3M | $7.9M | $2.0M | $975,000 | $680,000 | $60,000 | $989,000 | $1.0M | $1.6M | $223,000 |
| Gross profit | $63.5M | $19.9M | $31.5M | $6.5M | $5.3M | $1.9M | −$989,000 | $16.8M | −$1.6M | $489,000 |
| Research & development | $22.8M | $24.8M | $34.5M | $30.6M | $28.7M | $22.8M | $19.8M | $30.3M | $28.6M | $24.5M |
| Sales, general & admin | $9.4M | $10.0M | $10.0M | $11.3M | $11.7M | $10.7M | $9.1M | $9.7M | $8.8M | $8.5M |
| Total operating expenses | $32.2M | $34.8M | $44.4M | $41.9M | $40.4M | $33.4M | $28.9M | $40.0M | $37.4M | $33.1M |
| Operating income | $31.3M | −$14.9M | −$13.0M | −$35.4M | −$35.1M | −$31.5M | −$28.9M | −$23.2M | −$37.4M | −$32.6M |
| Interest income | $3.9M | $3.5M | $3.0M | $1.7M | $894,000 | $1.8M | $935,000 | $643,000 | $523,000 | $728,000 |
| Interest expense | — | $34,000 | $31,000 | $27,000 | $869,000 | $1.7M | $1.8M | $620,000 | $508,000 | $705,000 |
| Income before taxes | $35.4M | −$9.7M | −$9.8M | −$33.6M | −$34.2M | −$29.7M | −$28.1M | −$22.6M | −$37.1M | −$31.5M |
| Income taxes | $54,000 | $4.5M | $9.0M | $58,000 | −$1.3M | −$2.4M | −$722,000 | −$1.3M | −$678,000 | $20,000 |
| Net income | $35.3M | −$14.2M | −$18.8M | −$33.7M | −$32.9M | −$27.3M | −$27.3M | −$22.6M | −$37.1M | −$31.5M |
| EBITDA | $35.9M | −$9.2M | −$9.3M | −$34.9M | −$34.6M | −$30.8M | −$27.9M | −$21.8M | −$35.8M | −$31.1M |
| EPS (diluted) | $0.37 | −$0.16 | −$0.22 | −$0.40 | −$0.40 | −$0.37 | −$0.44 | −$0.40 | −$0.72 | −$0.62 |
| Gross margin | 87.3% | 71.5% | 94.0% | 87.0% | 88.7% | 97.0% | — | 94.2% | — | 68.7% |
| Operating margin | 43.1% | −53.4% | −38.8% | −471.7% | −584.6% | −1,574.8% | — | −130.5% | — | −4,576.3% |
| Net margin | 48.6% | −51.1% | −56.1% | −449.3% | −547.9% | −1,363.0% | — | −127.0% | — | −4,425.0% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.6M | $2.2M | $67.3M | $1.9M | $1.3M | $2.3M | $1.5M | $17.1M | $6.7M | $2.6M | $33.5M | $0 |
| Cost of revenue | $2.7M | $1.8M | $3.5M | $1.6M | $1.7M | $2.4M | $675,000 | $3.6M | $1.6M | $2.1M | $2.0M | $0 |
| Gross profit | −$92,000 | $352,000 | $63.8M | $241,000 | −$408,000 | −$116,000 | $796,000 | $13.5M | $5.2M | $457,000 | $31.5M | $0 |
| Research & development | $6.3M | $6.9M | $5.5M | $5.8M | $5.6M | $5.8M | $5.9M | $6.3M | $6.2M | $6.4M | $10.9M | $8.3M |
| Sales, general & admin | $2.4M | $2.4M | $2.2M | $2.3M | $2.4M | $2.5M | $2.4M | $2.7M | $2.4M | $2.5M | $2.5M | $2.3M |
| Total operating expenses | $8.7M | $9.4M | $7.8M | $8.1M | $8.0M | $8.3M | $8.3M | $9.0M | $8.6M | $8.9M | $13.5M | $10.6M |
| Operating income | −$8.8M | −$9.0M | $56.0M | −$7.9M | −$8.4M | −$8.4M | −$7.5M | $4.5M | −$3.4M | −$8.5M | $18.0M | −$10.6M |
| Interest income | $1.8M | — | $636,000 | $954,000 | $1.1M | — | $323,000 | $1.3M | $1.3M | — | $487,000 | $776,000 |
| Interest expense | — | — | — | — | — | — | — | — | — | — | $250,000 | — |
| Income before taxes | −$7.0M | −$7.7M | $56.8M | −$6.9M | −$7.4M | −$7.2M | −$6.1M | $5.8M | −$2.1M | −$7.3M | $18.7M | −$9.9M |
| Income taxes | $7,000 | $5,000 | — | $40,000 | −$17,000 | $31,000 | $4,000 | $4.5M | $11,000 | $3,000 | $9.0M | $39,586 |
| Net income | −$7.0M | −$7.7M | $56.8M | −$7.0M | −$7.3M | −$7.2M | −$6.1M | $1.3M | −$2.1M | −$7.3M | $9.7M | −$9.9M |
| EBITDA | −$7.0M | −$7.7M | $56.8M | −$6.9M | −$7.4M | −$7.2M | −$6.1M | $5.8M | −$2.1M | −$7.3M | $18.8M | −$9.9M |
| EPS (diluted) | −$0.07 | −$0.08 | $0.60 | −$0.07 | −$0.08 | −$0.08 | −$0.07 | $0.01 | −$0.02 | −$0.08 | $0.11 | −$0.11 |
| Gross margin | −3.5% | 16.2% | 94.7% | 12.7% | −32.5% | −5.1% | 54.1% | 79.0% | 76.8% | 17.9% | 94.0% | — |
| Operating margin | −339.6% | −414.4% | 83.2% | −417.4% | −670.6% | −367.6% | −508.7% | 26.2% | −50.9% | −331.8% | 53.7% | — |
| Net margin | −269.3% | −352.4% | 84.4% | −369.1% | −584.1% | −314.4% | −415.8% | 7.4% | −31.7% | −284.0% | 29.0% | — |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in CGEN's financial statements (latest annual report filed March 2, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
CGEN financial results
In fiscal year 2025 (ended December 31, 2025), Compugen reported revenue of $72.8 million, up 161.1% from the year before. It had net income of $35.3 million, a net profit margin of 48.6%. Diluted earnings per share came to $0.37. Over five years revenue grew at an average rate of 105.2% a year.
See the CGEN stock overview for the latest quote and news, or the CGEN chart for price history and technical indicators.
CGEN income statement FAQ
What is Compugen's annual revenue?
Compugen reported total revenue of $72.8 million for fiscal year 2025, which ended on December 31, 2025. That was up 161.1% from $27.9 million the previous year.
Is Compugen profitable?
Yes. Compugen reported net income of $35.3 million in fiscal 2025, a net profit margin of 48.6%; its operating margin was 43.1%.
What is Compugen's gross margin?
Compugen's gross margin was 87.3% in fiscal 2025: for every $100 of revenue, Compugen kept $87 after the direct cost of its products and services.
How much does Compugen spend on research and development?
Compugen spent $22.8 million on research and development in fiscal 2025, 31.3% of revenue.
How fast is Compugen growing?
Revenue grew 105.2% a year on average over the last five fiscal years, from $2.0 million to $72.8 million.
What are Compugen's earnings per share?
Compugen earned $0.37 per diluted share in fiscal 2025, compared with $-0.16 a year earlier.
When will Compugen report its next earnings?
Compugen is expected to report results for the quarter ending September 30, 2026 on November 9, 2026 before the market opens.
When does Compugen's fiscal year end?
Compugen's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on March 2, 2026.